Glimicut MP 1mg/500mg/15mg Tablet SR
Marketer
Elder Pharmaceuticals Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimicut MP 1mg/500mg/15mg Tablet SR
Metformin/Pioglitazone/Glimepiride extended-release tablets (1mg/500mg/15mg) manage blood glucose in adults with type 2 diabetes. This triple-combination therapy, used alongside diet and exercise, enhances insulin effectiveness, thus reducing blood sugar. Follow your physician's prescribed dosage and frequency; ingest with food to prevent digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; avoid doubling up. Excessive intake can cause hypoglycemia. Concurrent use with other diabetes medications, alcohol, or skipped meals raises hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, increased fracture risk, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation. Kidney function tests are performed before initiating therapy. Limit alcohol consumption to minimize potential side effects.
Uses of Glimicut MP 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimicut MP 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimicut MP 1mg/500mg/15mg Tablet SR whole; do not crush, chew, or divide it. Administer this extended-release tablet with a meal.
Common Side effects of Glimicut MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimicut MP 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimicut MP 1mg/500mg/15mg Sustained-Release tablets with food.
How Glimicut MP 1mg/500mg/15mg Tablet SR works:
Glimicut MP 1mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-action approach improves blood sugar management when single or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimicut MP 1mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimicut MP 1mg/500mg/15mg SR tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimicut MP 1mg/500mg/15mg tablet likely poses a risk during lactation. Preliminary data from humans indicates potential transfer to breast milk with the possibility of infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Glimicut MP 1mg/500mg/15mg Tablet SR, potentially requiring dosage modification. Medical consultation is necessary. Glimicut MP 1mg/500mg/15mg Tablet SR is contraindicated in patients experiencing severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimicut MP 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Medical advice is necessary. Glimicut MP 1mg/500mg/15mg Tablet SR is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glimicut MP 1mg/500mg/15mg Tablet SR :
Should you forget a Glimicut MP 1mg/500mg/15mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimicut MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Treatment |
3,018 People bought this recently